Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities

BACKGROUND: Patients with chromosome 5 abnormalities and high-risk myelodysplastic syndromes or acute myeloid leukemia have a poor outcome. We hypothesized that increasing doses of lenalidomide may benefit this group of patients by inhibiting the tumor clone, as assessed by fluorescence in situ hybr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Möllgård, Lars, Saft, Leonie, Treppendahl, Marianne Bach, Dybedal, Ingunn, Nørgaard, Jan Maxwell, Astermark, Jan, Ejerblad, Elisabeth, Garelius, Hege, Dufva, Inge Høgh, Jansson, Monika, Jädersten, Martin, Kjeldsen, Lars, Linder, Olle, Nilsson, Lars, Vestergaard, Hanne, Porwit, Anna, Grønbæk, Kirsten, Lindberg, Eva Hellström
Formato: Artigo
Idioma:Inglês
Publicado em: Ferrata Storti Foundation 2011
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3128214/
https://ncbi.nlm.nih.gov/pubmed/21719884
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2010.039669
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados